Last 12 months
Inside the activity.
0 purchase rows · 116 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 20 |
| Dec 2025 | 0 | 15 |
| Jan 2026 | 0 | 12 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 23 |
| May 2026 | 0 | 22 |
| Jun 2026 | 0 | 6 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 14, 2019 Filed Dec 17, 2019 18:45 UTC |
Casey Francis X.VP of Reg. and Qual. Assurance
|
Exercise / conversionRestricted Stock Units · Derivative | 425 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001508 · form4.xml · derivative · entry 3 Casey Francis X. · CIK 0001613661 · VP of Reg. and Qual. Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425 Underlying: Common Stock · 425 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2019 Filed Dec 17, 2019 18:45 UTC |
Casey Francis X.VP of Reg. and Qual. Assurance
|
Tax withholdingCommon Stock | 104 | $25.67 | $2,669.68 |
DisclosureSEC source: 0000898432-19-001508 · form4.xml · nonDerivative · entry 2 Casey Francis X. · CIK 0001613661 · VP of Reg. and Qual. Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,181 Read SEC document |
| December 14, 2019 Filed Dec 17, 2019 18:45 UTC |
Casey Francis X.VP of Reg. and Qual. Assurance
|
Exercise / conversionCommon Stock | 425 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-001508 · form4.xml · nonDerivative · entry 1 Casey Francis X. · CIK 0001613661 · VP of Reg. and Qual. Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,285 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2019 Filed Dec 17, 2019 18:52 UTC |
Nardi Steven M.VP Manufacturing
|
Exercise / conversionRestricted Stock Units · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001511 · form4.xml · derivative · entry 3 Nardi Steven M. · CIK 0001613663 · VP Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750 Underlying: Common Stock · 750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2019 Filed Dec 17, 2019 18:52 UTC |
Nardi Steven M.VP Manufacturing
|
Tax withholdingCommon Stock | 183 | $25.67 | $4,697.61 |
DisclosureSEC source: 0000898432-19-001511 · form4.xml · nonDerivative · entry 2 Nardi Steven M. · CIK 0001613663 · VP Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,422 Read SEC document |
| December 14, 2019 Filed Dec 17, 2019 18:52 UTC |
Nardi Steven M.VP Manufacturing
|
Exercise / conversionCommon Stock | 750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-001511 · form4.xml · nonDerivative · entry 1 Nardi Steven M. · CIK 0001613663 · VP Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,605 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2019 Filed Dec 17, 2019 18:49 UTC |
Waldman Louis S.Controller
|
Exercise / conversionRestricted Stock Units · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001510 · form4.xml · derivative · entry 3 Waldman Louis S. · CIK 0001613666 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750 Underlying: Common Stock · 750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2019 Filed Dec 17, 2019 18:49 UTC |
Waldman Louis S.Controller
|
Tax withholdingCommon Stock | 183 | $25.67 | $4,697.61 |
DisclosureSEC source: 0000898432-19-001510 · form4.xml · nonDerivative · entry 2 Waldman Louis S. · CIK 0001613666 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,427 Read SEC document |
| December 14, 2019 Filed Dec 17, 2019 18:49 UTC |
Waldman Louis S.Controller
|
Exercise / conversionCommon Stock | 750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-001510 · form4.xml · nonDerivative · entry 1 Waldman Louis S. · CIK 0001613666 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,610 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2019 Filed Dec 17, 2019 23:55 UTC |
JOHNSON BRENTExec. VP of Sales and Mktg
|
Exercise / conversionRestricted Stock Units · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001512 · form4.xml · derivative · entry 3 JOHNSON BRENT · CIK 0001254747 · Exec. VP of Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750 Underlying: Common Stock · 750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2019 Filed Dec 17, 2019 23:55 UTC |
JOHNSON BRENTExec. VP of Sales and Mktg
|
Tax withholdingCommon Stock | 296 | $25.67 | $7,598.32 |
DisclosureSEC source: 0000898432-19-001512 · form4.xml · nonDerivative · entry 2 JOHNSON BRENT · CIK 0001254747 · Exec. VP of Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,566 Read SEC document |
| December 14, 2019 Filed Dec 17, 2019 23:55 UTC |
JOHNSON BRENTExec. VP of Sales and Mktg
|
Exercise / conversionCommon Stock | 750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-001512 · form4.xml · nonDerivative · entry 1 JOHNSON BRENT · CIK 0001254747 · Exec. VP of Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,862 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2019 Filed Dec 17, 2019 23:47 UTC |
Scott Christopher K.Chief Fin. Officer and Sec.
|
Exercise / conversionRestricted Stock Units · Derivative | 3,417 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001509 · form4.xml · derivative · entry 3 Scott Christopher K. · CIK 0001613803 · Chief Fin. Officer and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,417 Underlying: Common Stock · 3,417 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2019 Filed Dec 17, 2019 23:47 UTC |
Scott Christopher K.Chief Fin. Officer and Sec.
|
Tax withholdingCommon Stock | 833 | $25.67 | $21,383.11 |
DisclosureSEC source: 0000898432-19-001509 · form4.xml · nonDerivative · entry 2 Scott Christopher K. · CIK 0001613803 · Chief Fin. Officer and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,978 Read SEC document |
| December 14, 2019 Filed Dec 17, 2019 23:47 UTC |
Scott Christopher K.Chief Fin. Officer and Sec.
|
Exercise / conversionCommon Stock | 3,417 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-001509 · form4.xml · nonDerivative · entry 1 Scott Christopher K. · CIK 0001613803 · Chief Fin. Officer and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2019 Filed Dec 16, 2020 21:57 UTC |
Scott Christopher K.CFO & Secretary
|
Tax withholdingCommon Stock | 1,344 | $24.59 | $33,048.96 |
DisclosureSEC source: 0000898432-20-001025 · form4.xml · nonDerivative · entry 2 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,595 Read SEC document |
| December 11, 2019 Filed Dec 12, 2019 00:28 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,300 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001501 · form4.xml · derivative · entry 9 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,468 Underlying: Common Stock · 4,300 shares Expires 2022-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F4 · derivative.exercise_date: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| December 11, 2019 Filed Dec 12, 2019 00:28 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 4,300 | $23.00 | $98,900.00 |
DisclosureSEC source: 0000898432-19-001501 · form4.xml · nonDerivative · entry 6 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,112 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. Read SEC document |
| December 11, 2019 Filed Dec 12, 2019 00:28 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 4,300 | $0.93 | $3,999.00 |
DisclosureSEC source: 0000898432-19-001501 · form4.xml · nonDerivative · entry 5 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,412 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. Read SEC document |
| December 10, 2019 Filed Dec 12, 2019 00:28 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001501 · form4.xml · derivative · entry 8 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,768 Underlying: Common Stock · 6,000 shares Expires 2022-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F4 · derivative.exercise_date: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| December 10, 2019 Filed Dec 12, 2019 00:28 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 6,000 | $22.48 | $134,880.00 |
DisclosureSEC source: 0000898432-19-001501 · form4.xml · nonDerivative · entry 4 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,112 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F3 · price: This transaction was executed in multiple trades at prices ranging from $22.45 to $22.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 10, 2019 Filed Dec 12, 2019 00:28 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 6,000 | $0.93 | $5,580.00 |
DisclosureSEC source: 0000898432-19-001501 · form4.xml · nonDerivative · entry 3 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,112 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. Read SEC document |
| December 10, 2019 Filed Dec 11, 2019 21:31 UTC |
VUOTO ANTHONYDirector
|
SaleCommon Stock | 4,347 | $22.37 | $97,242.39 |
DisclosureSEC source: 0000898432-19-001500 · form4.xml · nonDerivative · entry 1 VUOTO ANTHONY · CIK 0001222060 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,340 F1 · price: This transaction was executed in multiple trades at prices ranging from $22.37 to $22.44. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 09, 2019 Filed Dec 12, 2019 00:28 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0000898432-19-001501 · form4.xml · derivative · entry 7 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,768 Underlying: Common Stock · 6,000 shares Expires 2022-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F4 · derivative.exercise_date: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| December 09, 2019 Filed Dec 12, 2019 00:28 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
SaleCommon Stock | 6,000 | $22.53 | $135,180.00 |
DisclosureSEC source: 0000898432-19-001501 · form4.xml · nonDerivative · entry 2 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,112 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. F2 · price: This transaction was executed in multiple trades at prices ranging from $22.31 to $22.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 09, 2019 Filed Dec 12, 2019 00:28 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
GrantCommon Stock | 6,000 | $0.93 | $5,580.00 |
DisclosureSEC source: 0000898432-19-001501 · form4.xml · nonDerivative · entry 1 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,112 F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. Read SEC document |
| December 07, 2019 Filed Dec 11, 2019 02:14 UTC |
HAWKINS JAMES BDirector
|
GrantRestricted Stock Units · Derivative | 4,370 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001417 · form4.xml · derivative · entry 1 HAWKINS JAMES B · CIK 0000898243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,370 Underlying: Common Stock · 4,370 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2019 Filed Dec 10, 2019 21:16 UTC |
McCreery John KChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,082 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001420 · form4.xml · derivative · entry 3 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,248 Underlying: Common Stock · 1,082 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 7, 2018, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 7, 2018, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2019 Filed Dec 10, 2019 21:16 UTC |
McCreery John KChief Operating Officer
|
Tax withholdingCommon Stock | 264 | $22.88 | $6,040.32 |
DisclosureSEC source: 0000898432-19-001420 · form4.xml · nonDerivative · entry 2 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,387 Read SEC document |
| December 07, 2019 Filed Dec 10, 2019 21:16 UTC |
McCreery John KChief Operating Officer
|
Exercise / conversionCommon Stock | 1,082 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-001420 · form4.xml · nonDerivative · entry 1 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,651 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 07, 2019 Filed Dec 10, 2019 21:24 UTC |
Casey Francis X.VP of Reg. and Qual. Assurance
|
Exercise / conversionRestricted Stock Units · Derivative | 393 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001432 · form4.xml · derivative · entry 4 Casey Francis X. · CIK 0001613661 · VP of Reg. and Qual. Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,181 Underlying: Common Stock · 393 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: On December 7, 2018, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F4 · derivative.expiration_date: On December 7, 2018, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2019 Filed Dec 10, 2019 21:24 UTC |
Casey Francis X.VP of Reg. and Qual. Assurance
|
GrantRestricted Stock Units · Derivative | 1,748 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001432 · form4.xml · derivative · entry 3 Casey Francis X. · CIK 0001613661 · VP of Reg. and Qual. Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,748 Underlying: Common Stock · 1,748 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F3 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F3 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2019 Filed Dec 10, 2019 21:24 UTC |
Casey Francis X.VP of Reg. and Qual. Assurance
|
Tax withholdingCommon Stock | 96 | $22.88 | $2,196.48 |
DisclosureSEC source: 0000898432-19-001432 · form4.xml · nonDerivative · entry 2 Casey Francis X. · CIK 0001613661 · VP of Reg. and Qual. Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,860 Read SEC document |
| December 07, 2019 Filed Dec 10, 2019 21:24 UTC |
Casey Francis X.VP of Reg. and Qual. Assurance
|
Exercise / conversionCommon Stock | 393 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-001432 · form4.xml · nonDerivative · entry 1 Casey Francis X. · CIK 0001613661 · VP of Reg. and Qual. Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,956 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 07, 2019 Filed Dec 10, 2019 21:25 UTC |
Waldman Louis S.Controller
|
Exercise / conversionRestricted Stock Units · Derivative | 393 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001433 · form4.xml · derivative · entry 4 Waldman Louis S. · CIK 0001613666 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,181 Underlying: Common Stock · 393 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: On December 7, 2018, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F4 · derivative.expiration_date: On December 7, 2018, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2019 Filed Dec 10, 2019 21:25 UTC |
Waldman Louis S.Controller
|
GrantRestricted Stock Units · Derivative | 1,748 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001433 · form4.xml · derivative · entry 3 Waldman Louis S. · CIK 0001613666 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,748 Underlying: Common Stock · 1,748 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F3 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F3 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2019 Filed Dec 10, 2019 21:25 UTC |
Waldman Louis S.Controller
|
Tax withholdingCommon Stock | 96 | $22.88 | $2,196.48 |
DisclosureSEC source: 0000898432-19-001433 · form4.xml · nonDerivative · entry 2 Waldman Louis S. · CIK 0001613666 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,860 Read SEC document |
| December 07, 2019 Filed Dec 10, 2019 21:25 UTC |
Waldman Louis S.Controller
|
Exercise / conversionCommon Stock | 393 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-001433 · form4.xml · nonDerivative · entry 1 Waldman Louis S. · CIK 0001613666 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,956 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 07, 2019 Filed Dec 10, 2019 21:26 UTC |
Nardi Steven M.VP Manufacturing
|
Exercise / conversionRestricted Stock Units · Derivative | 393 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001434 · form4.xml · derivative · entry 4 Nardi Steven M. · CIK 0001613663 · VP Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,181 Underlying: Common Stock · 393 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: On December 7, 2018, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F4 · derivative.expiration_date: On December 7, 2018, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2019 Filed Dec 10, 2019 21:26 UTC |
Nardi Steven M.VP Manufacturing
|
GrantRestricted Stock Units · Derivative | 2,185 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001434 · form4.xml · derivative · entry 3 Nardi Steven M. · CIK 0001613663 · VP Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,185 Underlying: Common Stock · 2,185 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F3 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F3 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2019 Filed Dec 10, 2019 21:26 UTC |
Nardi Steven M.VP Manufacturing
|
Tax withholdingCommon Stock | 96 | $22.88 | $2,196.48 |
DisclosureSEC source: 0000898432-19-001434 · form4.xml · nonDerivative · entry 2 Nardi Steven M. · CIK 0001613663 · VP Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 855 Read SEC document |
| December 07, 2019 Filed Dec 10, 2019 21:26 UTC |
Nardi Steven M.VP Manufacturing
|
Exercise / conversionCommon Stock | 393 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-001434 · form4.xml · nonDerivative · entry 1 Nardi Steven M. · CIK 0001613663 · VP Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 951 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 07, 2019 Filed Dec 11, 2019 02:20 UTC |
VUOTO ANTHONYDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 1,968 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001427 · form4.xml · derivative · entry 3 VUOTO ANTHONY · CIK 0001222060 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,969 Underlying: Common Stock · 1,968 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: On December 7, 2018, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F4 · derivative.expiration_date: On December 7, 2018, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2019 Filed Dec 11, 2019 02:20 UTC |
VUOTO ANTHONYDirector
|
GrantRestricted Stock Units · Derivative | 4,370 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001427 · form4.xml · derivative · entry 2 VUOTO ANTHONY · CIK 0001222060 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,370 Underlying: Common Stock · 4,370 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F3 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F3 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2019 Filed Dec 11, 2019 02:20 UTC |
VUOTO ANTHONYDirector
|
Exercise / conversionCommon Stock | 1,968 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-001427 · form4.xml · nonDerivative · entry 1 VUOTO ANTHONY · CIK 0001222060 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,687 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 07, 2019 Filed Dec 11, 2019 02:22 UTC |
Scott Christopher K.Chief Fin. Officer and Sec.
|
Exercise / conversionRestricted Stock Units · Derivative | 1,574 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001431 · form4.xml · derivative · entry 4 Scott Christopher K. · CIK 0001613803 · Chief Fin. Officer and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,725 Underlying: Common Stock · 1,574 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: On December 7, 2018, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F4 · derivative.expiration_date: On December 7, 2018, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2019 Filed Dec 11, 2019 02:22 UTC |
Scott Christopher K.Chief Fin. Officer and Sec.
|
GrantRestricted Stock Units · Derivative | 10,926 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001431 · form4.xml · derivative · entry 3 Scott Christopher K. · CIK 0001613803 · Chief Fin. Officer and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,926 Underlying: Common Stock · 10,926 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F3 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F3 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2020. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2019 Filed Dec 11, 2019 02:22 UTC |
Scott Christopher K.Chief Fin. Officer and Sec.
|
Tax withholdingCommon Stock | 384 | $22.88 | $8,785.92 |
DisclosureSEC source: 0000898432-19-001431 · form4.xml · nonDerivative · entry 2 Scott Christopher K. · CIK 0001613803 · Chief Fin. Officer and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,394 Read SEC document |
| December 07, 2019 Filed Dec 11, 2019 02:22 UTC |
Scott Christopher K.Chief Fin. Officer and Sec.
|
Exercise / conversionCommon Stock | 1,574 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-001431 · form4.xml · nonDerivative · entry 1 Scott Christopher K. · CIK 0001613803 · Chief Fin. Officer and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,778 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 07, 2019 Filed Dec 11, 2019 02:21 UTC |
JOHNSON BRENTExec. VP of WW Sales and Mktg
|
Exercise / conversionRestricted Stock Units · Derivative | 393 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001430 · form4.xml · derivative · entry 3 JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,181 Underlying: Common Stock · 393 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 7, 2018, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 7, 2018, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.